As of January 2025, SK Biopharmaceuticals has a market cap of $5.61B. This makes SK Biopharmaceuticals the world's 2439th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.59B | -14.94% |
2023 | $5.39B | 39.25% |
2022 | $3.87B | -25.82% |
2021 | $5.22B | -42.49% |
2020 | $9.08B | - |